ALIVE Israel HealthTech Fund

A mid-late stage HealthTech Fund based on a unique strategic partnership model that accelerates portfolio companies clinical and commercial expansion.

[ALIVE Israel HealthTech Fund @AliveHealthTech]

ALIVE is extremely proud to welcome @cynerio —the recognized world leading industry provider of Healthcare IoT cybersecurity and asset management solutions—to its portfolio. Congratulations to CEO, Leon Lerman and the Cynerio team! To read more:

https://t.co/EMjV4yWM8m

[ALIVE Israel HealthTech Fund @AliveHealthTech]

ALIVE Managing Partners, Prof. Beyar and Michel Habib meet with the @Jerusalem_Post to discuss ALIVE and the rapid 2021 advancements and future of healthcare technology in Israel and globally.

Discover the full article.

https://t.co/YxC9LRcGFG

[ALIVE Israel HealthTech Fund @AliveHealthTech]

Exciting news- ALIVE just made its 3rd investment in digital therapeutics company, @Medisafe! Together with pharmaceutical giant @sanofi, we led the $30M Series C financing round.
A big congratulations to Medisafe on this exciting milestone! See more: https://t.co/tEq2SX1wLx.

[ALIVE Israel HealthTech Fund @AliveHealthTech]

Prof. Rafi Beyar, co-founder & managing general partner at ALIVE, is among 4.5 million+ Israelis vaccinated so far. He now encourages you to get yours!

#COVIDVaccine

[ALIVE Israel HealthTech Fund @AliveHealthTech]

What makes the ALIVE Israel HealthTech Fund unique?

Click play to hear it directly from the managing partners themselves!

#VentureCapital

https://t.co/8BuagJoWYr

[ALIVE Israel HealthTech Fund @AliveHealthTech]

It’s official, our new website is A-LIVE! Check it out → https://t.co/o3E2c3a9CB

Thank you, Pearlcom (@catypearl) for doing none other than a spectacular job on our website creation and branding!

[ALIVE Israel HealthTech Fund @AliveHealthTech]

How & why did 4, highly distinguished & experienced managing partners come to found ALIVE, Israel’s latest mid-to-late stage HealthTech fund?

#ForbesIsrael takes the time to get to find out.

Check out the article [https://t.co/xodLZ0M3ig], also published in 2021’s first issue!